LRRK2 and Parkinson disease: Defining the degree to which LRRK2 activity is elevated in PD patients with and without variants in LRRK2 is paramount for the clinical development of LRRK2 inhibitors and can help determine how much LRRK2 inhibition should be targeted as well as better identify which patient populations might benefit most from LRRK2 inhibition.